A detailed history of Lri Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lri Investments, LLC holds 4,190 shares of BMY stock, worth $242,014. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,190
Previous 2,642 58.59%
Holding current value
$242,014
Previous $110 Million 123.4%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$39.66 - $51.75 $61,393 - $80,109
1,548 Added 58.59%
4,190 $245 Million
Q2 2024

Jul 24, 2024

SELL
$40.25 - $52.99 $10,344 - $13,618
-257 Reduced 8.87%
2,642 $110 Million
Q1 2024

May 21, 2024

BUY
$47.98 - $54.4 $12,330 - $13,980
257 Added 9.73%
2,899 $157 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $126,763 - $143,724
2,642 New
2,642 $119 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lri Investments, LLC Portfolio

Follow Lri Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.